Literature DB >> 27852187

Prevention of breast cancer.

Ian N Olver1.   

Abstract

Modifiable lifestyle factors may reduce the risk of developing breast cancer. Obesity is associated particularly with post-menopausal breast cancer. Diet is important, and exercise equivalent to running for up to 8 hours each week reduces the risk of breast cancer, both in its own right and through reducing obesity. Alcohol consumption may be responsible for 5.8% of breast cancers in Australia and it is recommended to reduce this to two standard drinks per day. Drinking alcohol and smoking increases the risk for breast cancer and, therefore, it is important to quit tobacco smoking. Prolonged use of combined oestrogen and progesterone hormone replacement therapy and oral contraceptives may increase breast cancer risk and this must be factored into individual decisions about their use. Ionising radiation, either from diagnostic or therapeutic radiation or through occupational exposure, is associated with a high incidence of breast cancer and exposure may be reduced in some cases. Tamoxifen chemoprevention may reduce the incidence of oestrogen receptor positive cancer in 51% of women with high risk of breast cancer. Uncommon but serious side effects include thromboembolism and uterine cancer. Raloxifene, which can also reduce osteoporosis, can be used in post-menopausal women and is not associated with the development of uterine cancer. Surgical prophylaxis with bilateral mastectomy and salpingo-oophorectomy can reduce the risk of breast cancer in patients carrying BRCA1 or BRCA2 mutations. For preventive treatments, mammographic screening can identify other women at high risk.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27852187     DOI: 10.5694/mja16.01007

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  6 in total

1.  Incidence and survival outcomes of early male breast cancer: a population-based comparison with early female breast cancer.

Authors:  Yan Wang; Kai Chen; Yaping Yang; Luyuan Tan; Lili Chen; Liling Zhu; Fengxi Su; Xue Liu; Shunrong Li
Journal:  Ann Transl Med       Date:  2019-10

2.  Effects of Genistein and Synergistic Action in Combination with Tamoxifen on the HepG2 Human Hepatocellular Carcinoma Cell Line

Authors:  Masumeh Sanaei; Fraidoon Kavoosi; Shekoufeh Atashpour; Soheila Haghighat
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

3.  Applying Natural Language Processing to Understand Motivational Profiles for Maintaining Physical Activity After a Mobile App and Accelerometer-Based Intervention: The mPED Randomized Controlled Trial.

Authors:  Yoshimi Fukuoka; Teri G Lindgren; Yonatan Dov Mintz; Julie Hooper; Anil Aswani
Journal:  JMIR Mhealth Uhealth       Date:  2018-06-20       Impact factor: 4.773

4.  Breast Cancer Risk Factors: a Cross- Cultural Comparison between the West and the East

Authors:  Lina Kurdahi Badr; Laura Bourdeanu; Manal Alatrash; Garine Bekarian
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24

5.  Perceptions and Experiences of Women Participating in a Digital Technology-Based Physical Activity Intervention (the mPED Trial): Qualitative Study.

Authors:  Teri Lindgren; Julie Hooper; Yoshimi Fukuoka
Journal:  JMIR Public Health Surveill       Date:  2019-12-20

Review 6.  New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach.

Authors:  Magdalena Woźniczka; Katarzyna Błaszczak-Świątkiewicz
Journal:  Molecules       Date:  2021-10-27       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.